Next, we retrovirally introduced all MYD88 variants in DLBCL cell lines OCI-LY1 and OCI-LY7, which endogenously express wildtype MYD88 and display very weak basal NF-κB activation. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.